Concepedia

Josh Yuan

JY

6

Publications

171

Citations

6

H-Index

2000

Active since

Affiliations

Takeda (United States)(Current)

Takeda (Japan)

Takeda (Switzerland)

Josh Yuan is an author at Takeda (United States) specializing in clinical immunology, inflammatory arthritis, and tumor immunity.

Top concepts

Publications per year

2000–2019

6

Publications

6

Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human

Josh Yuan, Dai-chang Yang, Ji Y. Zhang et al. · Drug Metabolism and Disposition · 2002 · 53 citations

Pharmacokinetics and Metabolism of a COX-2 Inhibitor, Valdecoxib, in Mice

Ji Y. Zhang, Josh Yuan, Yue-Fen Wang et al. · Drug Metabolism and Disposition · 2003 · 40 citations

Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey

S. K. Paulson, J. Y. Zhang, Susan M. Jessen et al. · Xenobiotica · 2000 · 27 citations

A Reduction in B, T, and Natural Killer Cells Expressing CD38 by TAK-079 Inhibits the Induction and Progression of Collagen-Induced Arthritis in Cynomolgus Monkeys

Wouter Korver, Mary Carsillo, Josh Yuan et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 25 citations · Full text

TAK-079 is a high affinity monoclonal antibody that effectively mediates CD38+ cell depletion

Glennda Smithson, Jonathan Zalevsky, Wouter Korver et al. · The Journal of Immunology · 2017 · 14 citations

, , +19

Rows per page

1–5 of 6